{"id":"losartan-and-amlodipine","safety":{"commonSideEffects":[{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Fatigue"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Peripheral edema"},{"rate":null,"effect":"Hyperkalemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Losartan is an angiotensin II receptor antagonist (ARB) that prevents angiotensin II from binding to AT1 receptors, reducing peripheral vascular resistance and aldosterone-mediated sodium retention. Amlodipine is a dihydropyridine calcium channel blocker that inhibits L-type calcium influx in vascular smooth muscle, causing vasodilation. The combination provides complementary antihypertensive effects through different mechanisms.","oneSentence":"Losartan blocks angiotensin II receptors to reduce vasoconstriction and aldosterone release, while amlodipine blocks calcium channels to relax blood vessels, together lowering blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:10.899Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Hypertension in patients with left ventricular hypertrophy"}]},"trialDetails":[{"nctId":"NCT05370599","phase":"PHASE2","title":"Hypertension in Young Adults Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-04-15","conditions":"Hypertension","enrollment":36},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT04158154","phase":"NA","title":"Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series Design","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2020-02-01","conditions":"Hypertension","enrollment":21922},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT03946514","phase":"PHASE4","title":"Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-09-01","conditions":"Hypertension","enrollment":180},{"nctId":"NCT00157963","phase":"PHASE4","title":"Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-05","conditions":"Essential Hypertension","enrollment":174},{"nctId":"NCT00140959","phase":"PHASE4","title":"Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02-01","conditions":"Hypertension","enrollment":120},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT06366386","phase":"","title":"Integrating Hypertension Management in DSD for HIV","status":"NOT_YET_RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-06-15","conditions":"Hypertension, HIV","enrollment":1100},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT05954884","phase":"NA","title":"Community-based HEARTS Intervention (Pilot)","status":"UNKNOWN","sponsor":"National Heart Foundation of Bangladesh","startDate":"2023-08-01","conditions":"Hypertension","enrollment":400},{"nctId":"NCT05843162","phase":"PHASE4","title":"A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome","status":"UNKNOWN","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-06-01","conditions":"Essential Hypertension, Metabolic Syndrome","enrollment":116},{"nctId":"NCT03082014","phase":"PHASE3","title":"Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular Function","status":"TERMINATED","sponsor":"Ludwig-Maximilians - University of Munich","startDate":"2018-02-22","conditions":"Cerebral Small Vessel Diseases","enrollment":101},{"nctId":"NCT03666351","phase":"PHASE4","title":"Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-10-18","conditions":"Aortic Stenosis, Aortic Regurgitation, Hypertension","enrollment":128},{"nctId":"NCT03461003","phase":"PHASE4","title":"N-of-1 Trials In Children With Hypertension","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2018-04-02","conditions":"Pediatric Hypertension","enrollment":49},{"nctId":"NCT05462535","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-02-26","conditions":"Hypertension,Essential","enrollment":4785},{"nctId":"NCT05450575","phase":"","title":"An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-04-17","conditions":"Hypertension, Dyslipidemia","enrollment":5400},{"nctId":"NCT00231803","phase":"NA","title":"The Canadian Prevention of Renal and Cardiovascular Endpoints Trial","status":"COMPLETED","sponsor":"Brendan Barrett","startDate":"2005-04","conditions":"Chronic Kidney Disease","enrollment":474},{"nctId":"NCT00140985","phase":"PHASE4","title":"Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-02","conditions":"Renal Disorder","enrollment":97},{"nctId":"NCT01041807","phase":"","title":"Cozaar XQ Re-examination Study (MK-0954-349)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2010-02","conditions":"Hypertension","enrollment":669},{"nctId":"NCT02913664","phase":"PHASE2, PHASE3","title":"Risk Reduction for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2017-02-02","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":513},{"nctId":"NCT05212597","phase":"PHASE2","title":"Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2022-01-12","conditions":"Aortic Valve Insufficiency","enrollment":100},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT02278471","phase":"PHASE2","title":"The SCCS Polypill Pilot Trial","status":"COMPLETED","sponsor":"Vanderbilt University","startDate":"2015-12","conditions":"Hypertension, Hyperlipidemia","enrollment":303},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT00159692","phase":"PHASE4","title":"Amlodipine Diabetic Hypertension Efficacy Response Trial","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2003-03","conditions":"Hypertension","enrollment":739},{"nctId":"NCT04074551","phase":"PHASE3","title":"A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and Dyslipidemia","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2019-07-16","conditions":"Hypertension, Dyslipidemias","enrollment":145},{"nctId":"NCT03978884","phase":"PHASE4","title":"Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without Diabetes","status":"WITHDRAWN","sponsor":"The University of The West Indies","startDate":"2019-06-01","conditions":"Diabetes Mellitus, Hypertension","enrollment":""},{"nctId":"NCT04330300","phase":"PHASE4","title":"Coronavirus (COVID-19) ACEi/ARB Investigation","status":"SUSPENDED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2020-04-30","conditions":"Hypertension, COVID-19","enrollment":2414},{"nctId":"NCT04322266","phase":"PHASE1","title":"A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-12-21","conditions":"Healthy","enrollment":61},{"nctId":"NCT04081844","phase":"PHASE1","title":"A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2018-05-03","conditions":"Healthy","enrollment":31},{"nctId":"NCT03912285","phase":"PHASE1","title":"The Pharmacokinetic Interaction Between Amlodipine and Losartan","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2008-01-10","conditions":"Healthy","enrollment":24},{"nctId":"NCT02744456","phase":"EARLY_PHASE1","title":"N-of-1 Trials for Blood Pressure Medications in Adults","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-08-01","conditions":"Hypertension, High Blood Pressure","enrollment":10},{"nctId":"NCT01302691","phase":"PHASE3","title":"MK-0954E Study in Participants With Hypertension (MK-0954E-357)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-01-01","conditions":"Hypertension","enrollment":327},{"nctId":"NCT03626259","phase":"PHASE4","title":"Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial Hypertension","status":"UNKNOWN","sponsor":"Centro Universitario de Ciencias de la Salud, Mexico","startDate":"2018-08-06","conditions":"Hypertension","enrollment":28},{"nctId":"NCT03578042","phase":"PHASE4","title":"Fixed-Free HTN Trial","status":"UNKNOWN","sponsor":"Hotel Dieu de France Hospital","startDate":"2017-04-01","conditions":"Hypertension","enrollment":100},{"nctId":"NCT03147092","phase":"EARLY_PHASE1","title":"Matão Controlling Hypertension (MatCH Study): Rationale and Design","status":"UNKNOWN","sponsor":"Centro Neurológico de Pesquisa e Reabiitação, Brazil","startDate":"2018-02-01","conditions":"Hypertension, Blood Pressure","enrollment":15000},{"nctId":"NCT01648231","phase":"PHASE1","title":"Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-08-06","conditions":"Hypertension","enrollment":23},{"nctId":"NCT01797926","phase":"PHASE1","title":"Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting Conditions","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2013-05-23","conditions":"Hypertension","enrollment":102},{"nctId":"NCT01964079","phase":"PHASE4","title":"Comparision of Blood Pressure Variability Between Amlodipine and Losartan","status":"COMPLETED","sponsor":"Wonju Severance Christian Hospital","startDate":"2013-04","conditions":"Hypertension","enrollment":144},{"nctId":"NCT02294539","phase":"PHASE4","title":"Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive Patients","status":"COMPLETED","sponsor":"Chong-Jin Kim","startDate":"2014-08","conditions":"Hypertension","enrollment":231},{"nctId":"NCT02121041","phase":"NA","title":"Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot Study","status":"COMPLETED","sponsor":"Anthony J Viera, MD, MPH","startDate":"2014-05","conditions":"Hypertension","enrollment":28},{"nctId":"NCT02232880","phase":"PHASE2","title":"Treatment of Resistant Hypertension by Prevention of T-Cell Co-Stimulation","status":"TERMINATED","sponsor":"Vanderbilt University Medical Center","startDate":"2014-08","conditions":"Hypertension","enrollment":1},{"nctId":"NCT02916602","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2015-04","conditions":"Hypertension","enrollment":340},{"nctId":"NCT00940667","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2008-05","conditions":"Hypertension","enrollment":185},{"nctId":"NCT02900729","phase":"PHASE3","title":"Randomized Controlled Trial of Renal Denervation for Resistant Hypertension","status":"UNKNOWN","sponsor":"Shanghai WiseGain Medical Devices Co., Ltd.","startDate":"2016-10","conditions":"Hypertension","enrollment":254},{"nctId":"NCT01603940","phase":"PHASE4","title":"Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2012-05","conditions":"Hypertension, Diabetes Mellitus","enrollment":30},{"nctId":"NCT00805311","phase":"PHASE4","title":"Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis","status":"TERMINATED","sponsor":"Russian Cardiology Research and Production Center","startDate":"2009-04","conditions":"Carotid Artery Stenosis, Atherosclerosis, Stroke","enrollment":400},{"nctId":"NCT02504606","phase":"PHASE1","title":"Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject","status":"COMPLETED","sponsor":"Huons Co., Ltd.","startDate":"2014-09","conditions":"Hypertension","enrollment":60},{"nctId":"NCT02387554","phase":"PHASE1","title":"Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2014-08","conditions":"Hypertension(HTN)","enrollment":33},{"nctId":"NCT02166398","phase":"PHASE1","title":"A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male Volunteers","status":"COMPLETED","sponsor":"Korea United Pharm. Inc.","startDate":"2014-06","conditions":"Healthy","enrollment":46},{"nctId":"NCT00492128","phase":"PHASE4","title":"Kanagawa Combination Anti-hypertensive Therapy (K-CAT)","status":"COMPLETED","sponsor":"Yokohama City University Medical Center","startDate":"2007-09","conditions":"Hypertension","enrollment":196},{"nctId":"NCT01176032","phase":"PHASE4","title":"ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2010-06","conditions":"Hypertension, Left Ventricle Hypertrophy","enrollment":74},{"nctId":"NCT02140489","phase":"PHASE1","title":"Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin","status":"UNKNOWN","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2014-02","conditions":"Healthy","enrollment":30},{"nctId":"NCT00754429","phase":"PHASE4","title":"The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)","status":"COMPLETED","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2004-06","conditions":"Ischemic Stroke","enrollment":40},{"nctId":"NCT01713647","phase":"PHASE1","title":"Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions","status":"COMPLETED","sponsor":"Pharmaceutical Research Unit, Jordan","startDate":"2012-10","conditions":"Fasting","enrollment":39},{"nctId":"NCT01830517","phase":"PHASE4","title":"Diurnal Variation in Hypertensive Stroke Patients","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2007-08","conditions":"Hypertension, Stroke","enrollment":84},{"nctId":"NCT01828359","phase":"PHASE4","title":"The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-08","conditions":"Hypertension","enrollment":199},{"nctId":"NCT01198496","phase":"PHASE4","title":"Recurrent Stroke Prevention Clinical Outcome Study","status":"UNKNOWN","sponsor":"Biomedis International Ltd.","startDate":"2010-10","conditions":"Hypertension, Stroke, Blood Pressure","enrollment":5000},{"nctId":"NCT01180413","phase":"PHASE4","title":"Intensive Vasodilator Therapy in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Aarhus University Hospital","startDate":"2010-12","conditions":"Essential Hypertension, High Blood Pressure","enrollment":48},{"nctId":"NCT01409408","phase":"PHASE4","title":"Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan","status":"WITHDRAWN","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2011-04","conditions":"Hypertension, Diabetes Mellitus","enrollment":""},{"nctId":"NCT00237588","phase":"PHASE4","title":"Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)","status":"COMPLETED","sponsor":"Ullevaal University Hospital","startDate":"2004-12","conditions":"Hypertension","enrollment":25},{"nctId":"NCT00446563","phase":"PHASE3","title":"Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-03","conditions":"Hypertension; Hypertrophy, Left Ventricular","enrollment":90},{"nctId":"NCT01271374","phase":"PHASE4","title":"Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome","status":"UNKNOWN","sponsor":"InVasc Therapeutics, Inc.","startDate":"2010-04","conditions":"Hypertension","enrollment":80},{"nctId":"NCT01197014","phase":"PHASE1","title":"A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-09","conditions":"Healthy","enrollment":72},{"nctId":"NCT01197001","phase":"PHASE1","title":"A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and Losartan","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2010-08","conditions":"Healthy","enrollment":72},{"nctId":"NCT01198249","phase":"PHASE1","title":"Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-09","conditions":"Essential Hypertension","enrollment":23},{"nctId":"NCT00931710","phase":"PHASE4","title":"Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-07","conditions":"Stage 2 Systolic Hypertension","enrollment":488},{"nctId":"NCT01127217","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2009-05","conditions":"Hypertension","enrollment":149},{"nctId":"NCT00942344","phase":"PHASE2","title":"Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2007-05","conditions":"Hypertension","enrollment":320},{"nctId":"NCT00940680","phase":"PHASE3","title":"Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential Hypertension","status":"COMPLETED","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2008-04","conditions":"Hypertension","enrollment":142},{"nctId":"NCT00813722","phase":"PHASE4","title":"Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With Treatment","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"1999-03","conditions":"Blood Pressure","enrollment":400},{"nctId":"NCT00716950","phase":"PHASE4","title":"Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2008-07","conditions":"Essential Hypertension","enrollment":187},{"nctId":"NCT00669435","phase":"PHASE4","title":"Losartan and Simvastatin in Hypertensive Obeses With Liver Steatosis","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2008-04","conditions":"Hypertension","enrollment":75},{"nctId":"NCT00198562","phase":"PHASE4","title":"Hypertension Control Based on Home Blood Pressure","status":"UNKNOWN","sponsor":"Ministry of Health, Labour and Welfare, Japan","startDate":"2000-04","conditions":"Hypertension","enrollment":2600},{"nctId":"NCT00659451","phase":"PHASE3","title":"Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular","status":"UNKNOWN","sponsor":"University of Pavia","startDate":"2008-04","conditions":"Essential Hypertension, Diabetes Mellitus","enrollment":100}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"INTENTIONAL OVERDOSE"},{"count":2,"reaction":"SHOCK"},{"count":1,"reaction":"CATARACT"},{"count":1,"reaction":"EXTRA DOSE ADMINISTERED"},{"count":1,"reaction":"HEADACHE"},{"count":1,"reaction":"HIP FRACTURE"},{"count":1,"reaction":"LIMB INJURY"},{"count":1,"reaction":"NERVOUSNESS"},{"count":1,"reaction":"PRODUCT QUALITY ISSUE"},{"count":1,"reaction":"RADICULOPATHY"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Bicartial","Amosartan Tab. 5/50 mg, Amosartan Tab. 5/100 mg"],"phase":"marketed","status":"active","brandName":"Losartan and Amlodipine","genericName":"Losartan and Amlodipine","companyName":"Centro Universitario de Ciencias de la Salud, Mexico","companyId":"centro-universitario-de-ciencias-de-la-salud-mexico","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Losartan blocks angiotensin II receptors to lower blood pressure, while amlodipine blocks calcium channels to relax blood vessels and reduce cardiac workload. Used for Hypertension, Hypertension in patients with left ventricular hypertrophy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}